ARCH follows the science to found companies based on revolutionary technologies that can impact people’s lives and take a long-term view when building companies.
Longitude Capital specializes in making venture growth investments in biotechnology and medical technology companies that seek to improve clinical outcomes, enhance quality of life and/or reduce system costs.
Bluebird Ventures is an early stage life sciences venture capital firm. Founder Jeffrey Bird MD PhD has been a venture investor for nearly 20 years and was previously an executive at Gilead Sciences. He serves on the boards of Forty Seven, Inc. and Portola Pharmaceuticals as well as several private companies.
Adams Street Partners is a premier provider of global private markets investment management services. With over four decades of experience, ten offices in seven countries, and partnership investments spanning more than 30 nations.
Vertex Ventures HC invests in various sectors of the healthcare industry, including biopharmaceuticals, medical devices and digital health.
Seed and Series A VC with $37M under management, investing in breakthrough longevity companies. Longevity Fund companies have collected >$500M in follow-on funding, resulting in the 2018 IPO of the first company dedicated to reversing the diseases of aging.
October 13, 2020
Epirium Bio Appoints Alexander Casdin, Reneo Capital Management Founder, as Chief Financial Officer; Sandy Mahatme, Former Sarepta Therapeutics Chief Financial Officer and Chief Business Officer, Joins Board of Directors
December 18, 2019
Epirium Raises $85 Million in Series A Financing to Advance Unique Scientific Platform Focused on Restoration of Tissue Bioenergetics and Function